Sofinnova Ventures »

Jade Biosciences shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2025-09-30 $927k 107k 8.63
2025-06-30 $1.1M 107k 9.99

More positions owned by Sofinnova Ventures

Natera (NTRA)
Gilead Sciences (GILD)
United Therapeutics Corporation Put Option (UTHR)
Vera Therapeutics Cl A (VERA)
Jazz Pharmaceuticals Shs Usd (JAZZ)
AstraZeneca Sponsored Adr (AZN)
Rapport Therapeutics (RAPP)
Boston Scientific Corporation (BSX)
Uniqure NV SHS Call Option (QURE)
Dex (DXCM)
Intuitive Surgical (ISRG)
Axsome Therapeutics (AXSM)
Roivant Sciences SHS (ROIV)
iShares TR Ishares Biotech Put Option (IBB)
Vertex Pharmaceuticals Incorporated (VRTX)

View all positions for Sofinnova Ventures

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
Versant Venture Management
Rtw Investments
Frazier Life Sciences Management
Driehaus Capital Management
Avidity Partners Management
RA Capital Management
Soleus Capital Management
Geode Capital Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Jade Biosciences